Results 271 to 280 of about 4,259,087 (330)

Selective Class II HDAC Inhibitors Impair Myogenesis by Modulating the Stability and Activity of HDAC–MEF2 Complexes [PDF]

open access: yesEMBO Reports, 2009
Histone deacetylase (HDAC) inhibitors are promising new epi-drugs, but the presence of both class I and class II enzymes in HDAC complexes precludes a detailed elucidation of the individual HDAC functions.
Angela Nebbioso   +2 more
exaly   +3 more sources

Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)

Expert Opinion on Therapeutic Patents, 2020
Introduction: Histone deacetylase (HDAC) inhibitors play a crucial role in restoring the balance of acetylation and deacetylation of lysine residues of histones and non-histone proteins, which are applied to treat several diseases including cancer.
Chun-Long Zhao   +3 more
semanticscholar   +1 more source

HDAC Inhibitors

2016
Lysine acetylation in proteins is one of the most abundant posttranslational modifications in eukaryotic cells. The dynamic homeostasis of lysine acetylation and deacetylation is dictated by the action of histone acetyltransferases (HAT) and histone deacetylases (HDAC).
Heidi, Olzscha   +3 more
openaire   +2 more sources

Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.

European journal of medicinal chemistry, 2020
Despite the encouraging clinical progress of chemotherapeutic agents in cancer treatment, innovation and development of new effective anticancer candidates still represents a challenging endeavor. With 15 million death every year in 2030 according to the
A. Bass   +5 more
semanticscholar   +1 more source

Inside HDACs with more selective HDAC inhibitors

European Journal of Medicinal Chemistry, 2016
Inhibitors of histone deacetylases (HDACs) are nowadays part of the therapeutic arsenal mainly against cancers, with four compounds approved by the Food and Drug Administration. During the last five years, several groups have made continuous efforts to improve this class of compounds, designing more selective compounds or compounds with multiple ...
Roche, Joëlle, Bertrand, Philippe
openaire   +2 more sources

Synthetic approaches and clinical applications of representative HDAC inhibitors for cancer therapy: A review.

European journal of medicinal chemistry
Histone deacetylase (HDAC) inhibitors are a promising class of epigenetic modulators in cancer therapy. This review provides a comprehensive analysis of recent synthetic strategies and clinical applications of key HDAC inhibitors for oncology. HDACs play
Zhengming Lv   +4 more
semanticscholar   +1 more source

Teratogenic Activity of HDAC Inhibitors

Current Pharmaceutical Design, 2014
Modification of the terminal tails of histones is considered one of the documented mechanisms for epigenetic control of gene expression. Histone deacetylase inhibitors (HDACi) lead to a state of hyperacetylation of histone, a condition that can affect normal gene transcription.
E. Giavini, E. Menegola
openaire   +2 more sources

Highly Potent Dual BET/HDAC Inhibitors for the Efficient Treatment of Pancreatic Cancer.

Angewandte Chemie, 2020
As one of the most aggressive and lethal human malignancies with extremely poor prognosis, there is an urgent demand of more effective therapy for the treatment of pancreatic cancer.
Shi-Peng He   +5 more
semanticscholar   +1 more source

A Regulatory Circuit That Involves HR23B and HDAC6 Governs the Biological Response to HDAC Inhibitors

open access: yesCell Death and Differentiation, 2013
Histone deacetylase (HDAC) is an emergent anticancer target, and HR23B is a biomarker for response to HDAC inhibitors. We show here that HR23B has impacts on two documented effects of HDAC inhibitors; HDAC inhibitors cause apoptosis in cells expressing ...
Heidi Olzscha   +2 more
exaly   +2 more sources

Role of HDAC inhibitors in diabetes mellitus.

Current Research in Translational Medicine, 2020
OBJECTIVE The role of histone deacetylases has come out as an emerging remedy in control and treatment of various metabolic disorders and cancers. This review highlights their intricate role in diabetes mellitus as well as its associated complications.
R. Makkar, T. Behl, S. Arora
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy